| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 37,695 | $0.33 | $12,518.06 | - | - | - | |
| Nov 1, 2021 | DVAX Dynavax Technologies Corp | Novack David F73 | President &COO | Sell | 20,000 | $20.12 | $402,400.00 | -31.2% | -36.9% | -43.5% | |
| Nov 1, 2021 | MRK Merck & Co., Inc. | Gerberding Julie L. | EVP, Chief Patient Officer | Sell | 96,270 | $87.91 | $8,462,681.74 | -71.1% | -6.4% | +17.6% | |
| Nov 1, 2021 | MRK Merck & Co., Inc. | Clyburn Frank | EVP &Pres ? Human Health | Sell | 39,762 | $87.87 | $3,493,878.99 | -29.1% | -6.4% | +17.6% | |
| Oct 29, 2021 | MRK Merck & Co., Inc. | Chattopadhyay Sanat | Exe V-p &Pres. Mmd | Sell | 24,619 | $87.32 | $2,149,731.08 | -20.9% | -7.6% | +18.5% | |
| Oct 29, 2021 | MRK Merck & Co., Inc. | Deluca Richard R.45 | EVP&Pres, Merck Animal Heallth | Sell | 135,405 | $87.56 | $11,856,264.91 | -53.7% | -7.6% | +18.5% | |
| Oct 29, 2021 | CPIX Cumberland Pharmaceuticals Inc | Cearnal Martin E47 | Sr Vp/ Chief Commercial Officer | Buy | 2,205 | $2.72 | $5,998.65 | - | +22.7% | -6.3% | |
| Oct 29, 2021 | CPIX Cumberland Pharmaceuticals Inc | Galante Joseph C47 | Director | Buy | 2,982 | $2.72 | $8,112.46 | +0.3% | +22.7% | -6.3% | |
| Oct 29, 2021 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth55 | Director | Buy | 1,785 | $2.72 | $4,856.05 | - | +22.7% | -6.3% | |
| Oct 29, 2021 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 882 | $2.72 | $2,399.46 | +0.2% | +22.7% | -6.3% | |
| Oct 29, 2021 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 315 | $2.72 | $856.95 | - | +22.7% | -6.3% | |
| Oct 29, 2021 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 315 | $2.72 | $856.95 | +0.1% | +22.7% | -6.3% | |
| Oct 28, 2021 | BSPK Bespoke Extracts, Inc. | Pollack Danil | CEO | Sell | 50,000,001 | $0.00 | $40,000.00 | -39.7% | - | - | |
| Oct 28, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 178,631 | $253.24 | $45,236,369.47 | - | -5.8% | +44.1% | |
| Oct 27, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 21,369 | $252.33 | $5,391,997.03 | - | -4.0% | +44.4% | |
| Oct 25, 2021 | ZTS Zoetis Inc. | Chen Heidi C.47 | Executive Vice President | Sell | 9,446 | $210.22 | $1,985,738.12 | -28.2% | -5.1% | -27.5% | |
| Oct 25, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 63,400 | $0.31 | $19,482.00 | - | - | - | |
| Oct 22, 2021 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 1,315 | $208.03 | $273,559.45 | -6.1% | -2.9% | -28.9% | |
| Oct 21, 2021 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $190.18 | $1,141,081.50 | -7.3% | +7.6% | +15.0% | |
| Oct 19, 2021 | LNTH Lantheus Holdings, Inc. | Marshall Robert J. Jr.53 | CFO And Treasurer | Sell | 9,502 | $22.92 | $217,832.29 | -3.5% | +13.3% | +204.8% | |
| Oct 19, 2021 | LNTH Lantheus Holdings, Inc. | Montagut Etienne51 | Chief Business Officer | Sell | 4,112 | $22.92 | $94,245.11 | -2.4% | +13.3% | +204.8% | |
| Oct 18, 2021 | PTPI Petros Pharmaceuticals, Inc. | Shulman John D | Director, 10% Owner | Buy | 1,661,807 | $1.72 | $2,849,999.01 | +48.9% | - | - | |
| Oct 15, 2021 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 1,242 | $23.71 | $29,447.82 | -1.9% | +13.9% | +196.0% | |
| Oct 15, 2021 | BCRX Biocryst Pharmaceuticals Inc | Hutson Nancy J58 | Director | Sell | 105,000 | $15.40 | $1,617,000.00 | -61.7% | +6.7% | -10.6% | |
| Oct 12, 2021 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc.60 | 10% Owner | Sell | 165,100 | $5.03 | $830,670.47 | -1.8% | -17.2% | -58.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.